Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
President & Head of R & D, Director
-
Stock Symbol
-
RGLS on Nasdaq
Preston Klassen - trading volume in the past year for Regulus Therapeutics Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
36.1K |
$45.5K |
$1.26 |
Jan 13, 2025 |
Direct |
|
|
| Stock Option (Right to Buy) |
675K |
|
|
Jan 30, 2025 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.